« Previous
Next »
Titles
- Biochemic drug assay methods: with special reference to the pharmacodynamic standardization of drugs1
- Drug safety: preliminary findings indicate persistent challenges with FDA foreign inspections : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Observation sheet1
- Q11 development and manufacture of drug substances (chemical entities and biotechnological/biological entities): questions and answers1
- Q3D(R2) elemental impurities1
- Q7 good manufacturing practice guidance for active pharmaceutical ingredients: questions and answers1
- Report of Willis G. Tucker, M.D., Ph. D, analyst of drugs: to Woolsey Johnson, M.D., chairman of the Sanitary Committee of the State Board of Health of New York1
- Wholesale distributor verification requirement for saleable returned drug product: compliance policy1
- [Remedies for diabetes, gall stones, and heart conditions]1
